Loading...
Soligenix, Inc.
SNGX•NASDAQ
Healthcare
Biotechnology
$2.74
$-0.19(-6.48%)
Soligenix, Inc. (SNGX) Financial Performance & Income Statement Overview
Review Soligenix, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-85.78%
↓ 85.78%
Operating Income Growth
-22.62%
↓ 22.62%
Net Income Growth
-41.28%
↓ 41.28%
Operating Cash Flow Growth
2.33%
↑ 2.33%
Operating Margin
-454173.95%
↓ 454173.95%
Gross Margin
-67.81%
↓ 67.81%
Net Profit Margin
-271189.11%
↓ 271189.11%
ROE
-148.30%
↓ 148.30%
ROIC
-150.51%
↓ 150.51%
Soligenix, Inc. (SNGX) Income Statement & Financial Overview
Review Soligenix, Inc.'s (SNGX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $2342.00 | $117029.00 |
| Cost of Revenue | $0.00 | $0.00 | $3930.00 | $118617.00 |
| Gross Profit | $0.00 | $0.00 | -$1588.00 | -$1588.00 |
| Gross Profit Ratio | $0.00 | $0.00 | -$0.68 | -$0.01 |
| R&D Expenses | $2.66M | $968689.00 | $499570.00 | $1.09M |
| SG&A Expenses | $1.05M | $896547.00 | $1.24M | $1.02M |
| Operating Expenses | $3.71M | $1.87M | $1.74M | $2.12M |
| Total Costs & Expenses | $3.71M | $1.87M | $1.75M | $2.23M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $35925.00 | $28842.00 |
| Depreciation & Amortization | $1049.00 | $1589.00 | $1588.00 | $1588.00 |
| EBITDA | -$3.14M | -$1.86M | -$1.74M | -$1.92M |
| EBITDA Ratio | -$744.27 | -$16.41 | ||
| Operating Income | -$3.71M | -$1.87M | -$1.75M | -$2.23M |
| Operating Income Ratio | -$745.95 | -$19.09 | ||
| Other Income/Expenses (Net) | $316015.00 | $145855.00 | $100173.00 | $195433.00 |
| Income Before Tax | -$3.40M | -$1.72M | -$1.61M | -$1.92M |
| Income Before Tax Ratio | -$688.59 | -$16.42 | ||
| Income Tax Expense | -$409114.00 | $0.00 | $31819.00 | -$6331.00 |
| Net Income | -$2.99M | -$1.72M | -$1.64M | -$1.92M |
| Net Income Ratio | -$702.18 | -$16.37 | ||
| EPS | -$0.78 | -$0.78 | -$1.31 | -$2.91 |
| Diluted EPS | -$0.78 | -$0.78 | -$1.31 | -$2.91 |
| Weighted Avg Shares Outstanding | $2.20M | $2.20M | $1.26M | $657577.00 |
| Weighted Avg Shares Outstanding (Diluted) | $2.20M | $2.20M | $1.26M | $657577.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan